It has been shown that ICAM-1 levels were related to an elevation in cardiovascular mortality in patients with CAD [64,65], such that ICAM-1 levels were independently associated with ischemic reactive hyperemia in adults with OSA [50]. Here, ICAM1 is linked to obstructive sleep apnea syndrome.